2005
DOI: 10.1111/j.1778-428x.2005.tb00132.x
|View full text |Cite
|
Sign up to set email alerts
|

Adjuncts for Tissue stasis

Abstract: Preclinical and clinical data of products are outlined and the physical properties, mechanisms of action, and safety issues for each hemorrhage-control agent are discussed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2005
2005
2005
2005

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 121 publications
(161 reference statements)
0
1
0
Order By: Relevance
“…Hemorrhage control devices have been a major goal of the U.S. Department of Defense [36][37][38]. Three new devices have been fielded in the second Gulf War: a zeolite powder, a chitosan bandage, and the dry fibrin sealant bandage.…”
Section: New Technology For Hemorrhage Treatmentmentioning
confidence: 99%
“…Hemorrhage control devices have been a major goal of the U.S. Department of Defense [36][37][38]. Three new devices have been fielded in the second Gulf War: a zeolite powder, a chitosan bandage, and the dry fibrin sealant bandage.…”
Section: New Technology For Hemorrhage Treatmentmentioning
confidence: 99%